Publikationen von V. Cerovac

Cerovac, V.; Monteserin-Garcia, J.; Rubinfeld, H.; Buchfelder, M.; Losa, M.; Florio, T.; Paez-Pereda, M.; Stalla, G. K.; Theodoropoulou, M.: The Somatostatin Analogue Octreotide Confers Sensitivity to Rapamycin Treatment on Pituitary Tumor Cells. Cancer Research 70 (2), S. 666 - 674 (2010)

Cerovac, V.; Monteserin, J. L.; Stalla, G. K.; Theodoropoulou, M.: Octreotide enhances rapamycin's antiproliferative action by inhibiting rapamycin-induced IRS-1 and Akt activation. Experimental and Clinical Endocrinology & Diabetes 117 (10), S. 657 - 657 (2009)

Gorshtein, A.; Rubinfeld, H.; Kendler, E.; Theodoropoulou, M.; Cerovac, V.; Stalla, G. K.; Cohen, Z. R.; Hadani, M.; Shimon, I.: Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro. Endocrine-Related Cancer 16 (3), S. 1017 - 1027 (2009)

Cerovac, V.; Reimann, M.; Stalla, G. K.; Theodoropoulou, M.: Modulation of cell cycle progression by combined rapamycin-octreotide treatment in pituitary tumor cells. Experimental and Clinical Endocrinology & Diabetes 115 (8), S. 551 - 551 (2007)